Texas Capital Bancshares ... (TCBIO)
Texas Capital Bancshares Statistics
Share Statistics
Texas Capital Bancshares has 46.12M shares outstanding. The number of shares has increased by null% in one year.
Shares Outstanding | 46.12M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Institutions (%) | 0% |
Shares Floating | - |
Failed to Deliver (FTD) Shares | 3.32K |
FTD / Avg. Volume | 12.14% |
Short Selling Information
Short Interest | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is 46.61 and the forward PE ratio is null. Texas Capital Bancshares's PEG ratio is -1.09.
PE Ratio | 46.61 |
Forward PE | n/a |
PS Ratio | 2.09 |
Forward PS | 0.7 |
PB Ratio | 1.07 |
P/FCF Ratio | 7.51 |
PEG Ratio | -1.09 |
Enterprise Valuation
Texas Capital Bancshares has an Enterprise Value (EV) of 3.89B.
EV / Sales | 2.25 |
EV / EBITDA | 0 |
EV / EBIT | 8.09 |
EV / FCF | 8.09 |
Financial Position
The company has a current ratio of 10.31, with a Debt / Equity ratio of 0.14.
Current Ratio | 10.31 |
Quick Ratio | 10.31 |
Debt / Equity | 0.14 |
Debt / EBITDA | - |
Debt / FCF | 1.01 |
Interest Coverage | 2.06 |
Financial Efficiency
Return on Equity is 2.3% and Return on Invested Capital is 557.04%.
Return on Equity | 2.3% |
Return on Assets | 2% |
Return on Invested Capital | 557.04% |
Revenue Per Employee | $951.35K |
Profits Per Employee | $42.63K |
Employee Count | 1,818 |
Asset Turnover | 0.45 |
Inventory Turnover | n/a |
Taxes
Income Tax | 29.55M |
Effective Tax Rate | 27.6% |
Stock Price Statistics
The stock price has increased by 0.58% in the last 52 weeks. The beta is 0.74, so Texas Capital Bancshares's price volatility has been higher than the market average.
Beta | 0.74 |
52-Week Price Change | 0.58% |
50-Day Moving Average | 20.17 |
200-Day Moving Average | 20.53 |
Relative Strength Index (RSI) | 44.93 |
Average Volume (20 Days) | 27.32K |
Income Statement
In the last 12 months, Texas Capital Bancshares had revenue of 1.73B and earned 77.51M in profits. Earnings per share was 2.05.
Revenue | 1.73B |
Gross Profit | 1.73B |
Operating Income | 1.71B |
Net Income | 77.51M |
EBITDA | 0 |
EBIT | 935.31M |
Earnings Per Share (EPS) | 2.05 |
Balance Sheet
The company has 205.38M in cash and 485.63M in debt, giving a net cash position of -280.25M.
Cash & Cash Equivalents | 205.38M |
Total Debt | 485.63M |
Net Cash | -280.25M |
Retained Earnings | 2.47B |
Total Assets | 31.38B |
Working Capital | 3.1B |
Cash Flow
In the last 12 months, operating cash flow was 481.12M and capital expenditures 0, giving a free cash flow of 481.12M.
Operating Cash Flow | 481.12M |
Capital Expenditures | 0 |
Free Cash Flow | 481.12M |
FCF Per Share | 10.41 |
Margins
Gross margin is 100%, with operating and profit margins of 98.71% and 4.48%.
Gross Margin | 100% |
Operating Margin | 98.71% |
Pretax Margin | 6.19% |
Profit Margin | 4.48% |
EBITDA Margin | n/a |
EBIT Margin | 98.71% |
FCF Margin | 27.82% |
Dividends & Yields
TCBIO pays an annual dividend of $1.44, which amounts to a dividend yield of 6.94%.
Dividend Per Share | $1.44 |
Dividend Yield | 6.94% |
Dividend Growth (YoY) | 0% |
Payout Ratio | 36.31% |
Earnings Yield | 2.15% |
FCF Yield | 13.32% |
Analyst Forecast
Currently there are no analyst rating for TCBIO.
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Scores
Altman Z-Score | 0.31 |
Piotroski F-Score | 9 |